Senior insider sale
CHIEF OPERATING OFFICER at ENLIVEN THERAPEUTICS, INC. — senior position signals high conviction
$4.43M
148.30K shares
What this filing means
PATEL ANISH plans to sell 148.30K shares of ENLIVEN THERAPEUTICS, INC. valued at approximately $4.43M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/24/2026ACC: 0001974158-26-000025
Officer· CHIEF OPERATING OFFICER
Since Feb 2026
148.30K
Shares to sell
$4.43M
Approx. market value
100K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Founder shares
N/A
9/1/2019
100KTotal acquired100K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/1/2019 | Founder shares N/A | 100K | — |
| Total | 100K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
48.30K
Market value
$1.35M
1/9/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
100K
Market value
$3.08M
3/24/2026
Total
Units
148.30K
Value
$4.43M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/9/2026 | 48.30K | $1.35M | — | Completed |
| Planned — Approximate Date | ||||
3/24/2026 | 100K | $3.08M | Nasdaq | Planned |
| Total | 148.30K | $4.43M | ||